Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases

Eaden, 2001, The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gut, 48, 526, 10.1136/gut.48.4.526 Bernstein, 2001, Cancer risk in patients with inflammatory bowel disease: a population-based study, Cancer, 91, 854, 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z Laine, 2015, SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease, Gastroenterology, 148, 639, 10.1053/j.gastro.2015.01.031 Subramanian, 2013, Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease, Inflamm Bowel Dis, 19, 350, 10.1002/ibd.23002 Subramanian, 2011, Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease, Aliment Pharmacol Ther, 33, 304, 10.1111/j.1365-2036.2010.04525.x Rutter, 2014, Colorectal dysplasia in inflammatory bowel disease: a clinicopathologic perspective, Clin Gastroenterol Hepatol, 12, 359, 10.1016/j.cgh.2013.05.033 Cairns, 2010, Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002), Gut, 59, 666, 10.1136/gut.2009.179804 Kornbluth, 2010, Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee, Am J Gastroenterol, 105, 501, 10.1038/ajg.2009.727 Marion, 2015, The SCENIC consensus statement on surveillance and management of dysplasia in inflammatory bowel disease: praise and words of caution, Gastroenterology, 148, 462, 10.1053/j.gastro.2015.01.029 Annese, 2013, European evidence based consensus for endoscopy in inflammatory bowel disease, J Crohns Colitis, 7, 982, 10.1016/j.crohns.2013.09.016 Riddell, 1983, Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications, Hum Pathol, 14, 931, 10.1016/S0046-8177(83)80175-0 Wanders, 2014, Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis, Clin Gastroenterol Hepatol, 12, 756, 10.1016/j.cgh.2013.07.024 Rubin, 1999, Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps, Gastroenterology, 117, 1295, 10.1016/S0016-5085(99)70279-9 Itzkowitz S. Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice. J Clin Gastroenterol 36:S70–S74, discussion S94–S96. Choi, 2015, Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer, Am J Gastroenterol, 110, 1461, 10.1038/ajg.2015.248 Bernstein, 1999, ALMs versus DALMs in ulcerative colitis: polypectomy or colectomy?, Gastroenterology, 117, 1488, 10.1016/S0016-5085(99)70300-8 van den Broek, 2014, Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences, Am J Gastroenterol, 109, 715, 10.1038/ajg.2011.93 East, 2014, Endoscopic management of nonpolypoid colorectal lesions in colonic IBD, Gastrointest Endosc Clin N Am, 24, 435, 10.1016/j.giec.2014.03.003 Blonski, 2008, High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis, Scand J Gastroenterol, 43, 817, 10.1080/00365520801909686